My Cart


Potential Cancer Causing Chemical Found In Blood Pressure Medication

Written by Jonathan Hamilton


Posted on 20 June 2019

For the fourth time in the past year, a widely used blood pressure medication is under review amid concerns it could contain chemicals that could potentially cause cancer.

an online pharmacy in the USA, has alerted the Food and Drug Administration of high levels of dimethylformamide (DMF) in valsartan, which is produced by several pharmaceutical companies and often combined with other medicines into a single pill.

DMF is classified as a probable human carcinogen by the World Health Organization and the American Cancer Society.

The pharmacy is asking a recall for the pills and requesting the FDA revise its acceptable intake levels of DMF from the current level of 8,800,000 nanograms to under 1,000 nanograms. The FDA has not yet responded to that request. The government agency is evaluating the findings.

Valisure says it found excessive DMF levels in valsartan products from six companies.

Blood pressure medications have been put under increasing scrutiny of late, with several recalls in the past year.



Leave a Comment